SynthesisJournal of clinical hypertension (Greenwich, Conn.)2021

Is the newest angiotensin-receptor blocker azilsartan medoxomil more efficacious in lowering blood pressure than the older ones? A systematic review and network meta-analysis.

Ji-Guang Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.